Acorda Therapeutics, Inc. Restructuring Costs
Acorda Therapeutics, Inc. reported Restructuring Costs of $1.47 million for the 12-month period ending 2017-12-31, per its 10-K/A filed 2018-03-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2018-03-09
- Acorda Therapeutics, Inc. restructuring costs for the quarter ending 2017-12-31 was -$406.00K.
- Acorda Therapeutics, Inc. restructuring costs for the quarter ending 2017-09-30 was -$406.00K.
- Acorda Therapeutics, Inc. restructuring costs for fiscal 2017 was $1.47M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$406.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-09 | -$812.00K derived: sum of 2 quarters · filed 2018-03-09 | $1.47M 10-K/A · filed 2018-03-09 | |
| 2017-09-30 | -$406.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.88M 10-Q · filed 2017-11-07 | ||
| 2017-06-30 | $2.28M 10-Q · filed 2017-08-08 |